In some cases involving the False Claims Act (“FCA”), extensive discovery requests, procedural strategy and legal maneuvering cause unnecessary delays often resulting in years of litigation. While this is not necessarily the norm in every FCA case, it was certainly true in the government’s FCA case against Science International Applications […]
In yesterday’s post, we explored the important partnership between the federal False Claims Act “(FCA”) and the Stark Law – a lesser-known, equally-vital statute enacted to combat healthcare fraud in the form of unfair kickbacks and referral fees. The FCA and the Stark Law are often used in conjunction with […]
An emergence of whistleblower cases citing the Stark Law has prompted us to take a look at this important piece of legislation – and how it intersects with the False Claims Act (“FCA”). Both statutes work to help eliminate fraud against the U.S. government. However, the Stark Law is more […]
In a recently-revealed False Claims Act case, the United States has elected to intervene against Naples, Florida-based Health Management Associates, Inc. after uncovering serious allegations of fraud. Currently, four whistleblower cases are pending against the company both in the Middle District of Georgia and Southern District of Florida. The cases […]
The drug OxyContin has been widely publicized for its tendency to lead patients toward unintended opiate addiction, often resulting in misuse and eventual dependence. The drug is also favored among younger children eager to experiment with illicit drugs without having to venture beyond the medicine cabinet. For these reasons, OxyContin […]